Evaluation of rifalazil in a combination treatment regimen as an alternative to isoniazid-rifampin therapy in a mouse tuberculosis model

Antimicrobial Agents and Chemotherapy

Volumn 44, Issue 11, 2000, Pages 3167-3168

  Lenaerts, A M ^a   Chase, S E ^a   Cynamon, M H ^a  

^a SYRACUSE VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOSTERILANT; ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFALAZIL; RIFAMPICIN; RIFAMYCIN DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBACTERIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENCY; FEMALE; LONG TERM CARE; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; RELAPSE; TUBERCULOSIS;

ANIMALS; ANTITUBERCULAR AGENTS; COLONY-FORMING UNITS ASSAY; DISEASE MODELS, ANIMAL; DRUG THERAPY, COMBINATION; ETHAMBUTOL; FEMALE; ISONIAZID; MICE; PYRAZINAMIDE; RIFAMPIN; RIFAMYCINS; TUBERCULOSIS;

EID: 0033743936     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.44.11.3167-3168.2000     Document Type: Article

References (16)

1. Evaluation of once-weekly therapy for tuberculosis using isoniazid plus rifamycins in the mouse aerosol infection model
2. Preventive therapy of tuberculosis with rifapentine in immunocompetent and nude mice
3. Comparative in vitro activities of MDL-473, rifamycin, and ansamycin against Mycobacterium intracellulare
4. The Fisher exact test
5. Activity of two long-acting rifamycins, rifapentine and FCE 22807, in experimental murine tuberculosis
6. Activity in vitro of rifabutin, FCE 22807, rifapentine, and rifampin against Mycobacterium microti and M. tuberculosis and their penetration into mouse peritoneal macrophages
7. Once-weekly rifapentine-containing regimens for treatment of tuberculosis in mice
8. Effectiveness of rifampin, rifabutin, and rifapentine for preventive therapy of tuberculosis in mice
9. Low-dose aerosol infection model for testing drugs for efficacy against Mycobacterium tuberculosis
10. Activity of KRM-1648 in combination with isoniazid against Mycobacterium tuberculosis in a murine model
11. Activity of KRM-1648, a new benzoxazinorifamycin, against Mycobacterium tuberculosis in a murine model
12. Activity of levofloxacin in a murine model of tuberculosis
13. Evaluation of rifapentine in long-term treatment regimens for tuberculosis in mice
14. Comparative antimicrobial activities of rifampin, rifapentine and KRM-1648 against a collection of rifampin-resistant Mycobacterium tuberculosis isolates with known rpoB mutations
15. Comparison of activities of rifapentine and rifampin against Mycobacterium tuberculosis residing in human macrophages
16. Evaluation of rifalazil in long-term treatment regimens for tuberculosis in mice